Patents Assigned to Suzhou Longbotai Pharmaceuticals Co., Ltd.
  • PDE4 INHIBITOR COMPOUND AND MEDICAL USE THEREOF
    Publication number: 20230141101
    Abstract: A class of PDE4 inhibitor compounds, and an isomer, solvate, deuterated derivative, or pharmaceutically acceptable salt thereof. A drug that comprises the compound, isomer, solvate, deuterated derivative, and pharmaceutically acceptable salt thereof, and a use thereof in preparing a drug for treating diseases related to PDE4 inhibition, such as autoimmune diseases and cancer.
    Type: Application
    Filed: February 22, 2021
    Publication date: May 11, 2023
    Applicant: Suzhou Longbotai Pharmaceuticals Co., Ltd.
    Inventors: Shuxin Li, Hengying Yang, Sheng Kuang, Sifan She, Kuiwang Wu, Shiwei Li